Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.
Opportunity | Posted | Closing |
---|---|---|
Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCCIHNIANIDANCI | 10/26/23 | 04/16/24 |
Agency: NIH Institutions: NCI | 10/16/23 | 12/04/24 |
Agency: NIH Institutions: NIMHDNIANINRNCIORWH | 10/12/23 | 01/06/27 |
Agency: NIH Institutions: NCI | 10/10/23 | 10/13/26 |
Agency: NIH Institutions: NIAID | 10/10/23 | 03/13/24 |
2024 Human Exploration Research Opportunities (HERO) Overview Agency: JSC | 10/03/23 | 09/30/24 |
Agency: NIH Institutions: NCI | 09/29/23 | 01/07/27 |
Agency: NIH Institutions: NIMHDNEINIANIAAANIAMSNIBIBNICHDNIDCDNINDSNINRNCISGMROOBSSR | 09/26/23 | 11/05/26 |
Agency: NIH Institutions: NCINIDCR | 09/22/23 | 09/25/26 |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 09/21/23 | 01/07/27 |
Agency: NIH Institutions: NCI | 09/21/23 | 01/07/27 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCI | 09/12/23 | 09/07/25 |
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAANIAIDNIAMSNIBIBNIDCRNIDDKNIEHSNIMHNINRNIMHDNLMNCIODPOBSSRORWH | 09/11/23 | 01/07/27 |
Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) Agency: NIH Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCIODPOBSSRORWH | 09/11/23 | 01/07/27 |
Agency: NIH Institutions: NCISGMRO | 09/07/23 | 01/07/27 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCI | 09/07/23 | 09/07/25 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNCCIHNCI | 09/07/23 | 09/07/25 |
Agency: NIH Institutions: ODSSNEINHLBINHGRINIANIAAANIAMSNIBIBNIDCRNIDANIEHSNIGMSNINDSNIMHDNCCIHNCI | 08/30/23 | 01/25/26 |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/24/23 | 01/07/27 |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 08/23/23 | 01/07/27 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/21/23 | 11/19/24 |
Agency: NIH Institutions: NCI | 08/18/23 | 09/07/26 |
Agency: NIH Institutions: ODPNIAAANIDCRNIDANIMHDSGMRONCIORWH | 08/16/23 | 05/07/27 |
Agency: NIH Institutions: NIHNEINHLBINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINRNIMHDNCCIHNCI | 08/16/23 | 09/07/25 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNIMHDNLMNCCIHNCI | 08/16/23 | 09/07/25 |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAA | 08/15/23 | 01/07/27 |
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANIAAANIEHSNIMHNIMHDNCIOBSSRORWH | 08/11/23 | 05/05/26 |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Agency: NIH Institutions: NCI | 08/10/23 | 05/07/26 |
Agency: NIH Institutions: NCI | 08/10/23 | 09/07/26 |
Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNICHDNIDCRNIDANCCIHNCI | 08/10/23 | 02/06/25 |
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/09/23 | 11/03/25 |
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/09/23 | 11/03/25 |
Agency: NIH Institutions: NCI | 08/08/23 | 01/07/27 |
Agency: NIH Institutions: NCINHGRINIANIDCR | 08/01/23 | 09/07/26 |
Agency: NIH Institutions: NCINHGRINIANIDCR | 08/01/23 | 09/07/26 |
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 07/20/23 | 05/04/26 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDANIEHSNIMHNINRNIMHDNCCIHNCI | 07/12/23 | 04/05/24 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSNCIORIP | 07/12/23 | 04/05/24 |
Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDDKNIDANIEHSNIMHNINRNIMHDNCCIHNCINIOSH | 07/12/23 | 04/05/24 |
Agency: NIH Institutions: ODNEINHLBINHGRINIAAANIAIDNIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIMHNINDSNCATSNCI | 07/12/23 | 04/05/25 |
ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNEINIAMSNIDCDNINDSNCATSNCI | 06/06/23 | 05/25/25 |
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Agency: NIH Institutions: NHGRINIANCIORWH | 06/05/23 | 07/08/25 |
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) Agency: NIH Institutions: NIGMSNHGRINIANIAAANIAMSNICHDNIDCRNIDDKNIDANIEHSNIMHNINDSNIMHDNCCIHNCIORWHODSS | 06/02/23 | 08/07/26 |
Agency: NIH Institutions: NHGRINIDCRNIEHSNINDSNCI | 05/26/23 | 07/08/26 |
Agency: NIH Institutions: FICNIDCRNIDDKNIDANIMHNCI | 05/10/23 | 12/08/25 |
Agency: NIH Institutions: FICNIDCRNIDDKNIDANIMHNCI | 05/10/23 | 12/22/25 |
Tobacco Regulatory Science (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNHLBINIDANIEHSNCI | 05/03/23 | 05/04/25 |
Agency: NIH Institutions: NINDSNEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANCCIHNCI | 04/27/23 | 06/09/25 |
Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 04/20/23 | 07/03/24 |
Agency: NIH Institutions: ODPNIDCRNIMHDNCIORWH | 04/19/23 | 01/07/27 |
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 03/30/23 | 05/07/26 |
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 03/30/23 | 05/07/26 |
Agency: NIH Institutions: NCI | 03/23/23 | 06/13/25 |
Synthesis Center for Understanding Organismal Resilience Agency: NSF | 03/21/23 | 07/15/24 |
Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) Agency: NIH Institutions: ORWHNHLBINIANIAMSNICHDNCI | 03/09/23 | 06/20/24 |
Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDOARNHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFICNCI | 03/09/23 | 08/04/25 |
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDOARNHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFICNCI | 03/09/23 | 08/04/25 |
NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINEINHLBINHGRINIANIDCDNIDANIEHSNCATS | 03/09/23 | 08/08/25 |
Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) Agency: NIH Institutions: ORWHNHLBINIANIAMSNICHDNCI | 03/08/23 | 06/20/24 |
Genomic Community Resources (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NHGRINCI | 03/01/23 | 01/25/26 |
Agency: NIH Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNCIORIPODSS | 01/26/23 | 05/07/26 |
Agency: NIH Institutions: NICHDNIDCRNCI | 12/23/22 | 01/07/26 |
Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNCCIHNCI | 12/15/22 | 03/11/25 |
Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNCCIHNCI | 12/15/22 | 03/11/25 |
Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNCCIHNCI | 12/15/22 | 03/11/25 |
Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNCCIHNCI | 12/15/22 | 03/11/25 |
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 12/14/22 | 11/05/25 |
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 12/14/22 | 11/16/25 |
Agency: NIH Institutions: NCI | 12/14/22 | 05/07/26 |
Agency: NIH Institutions: NCI | 12/05/22 | 01/07/26 |
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 11/23/22 | 01/07/26 |
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Agency: NIH Institutions: NIAID | 11/23/22 | 11/17/25 |
Agency: NIH Institutions: NCI | 11/21/22 | 10/23/25 |
Agency: NIH Institutions: NCI | 11/21/22 | 10/23/25 |
Agency: NIH Institutions: NIAID | 10/31/22 | 03/14/25 |
Agency: NIH Institutions: ODNEINHLBINIANIAIDNICHDNIDCDNCIORIP | 10/13/22 | 05/25/25 |
Agency: NIH Institutions: ODNEINHLBINIANICHDNIDCDNIDCRNINDSNIMHDFICNCI | 10/03/22 | 09/07/25 |
Department of Defense HIV/AIDS Prevention Program Agency: AMRAA | 09/19/22 | 09/18/27 |
Agency: NIH Institutions: NINDSNHLBINIANIAAANIAMSNICHDNIGMSNIMHNCCIHNCATSNCIORIP | 09/15/22 | 04/04/25 |
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 09/13/22 | 09/07/25 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) Agency: NIH Institutions: NCININDS | 09/08/22 | 09/07/25 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINIAMSNIDCDNIDCRNINDS | 09/08/22 | 09/07/25 |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/25/22 | 06/20/25 |
Agency: NIH Institutions: NIDDKNHLBINICHDNCI | 08/24/22 | 05/01/25 |
Agency: NIH Institutions: NIBIBNEINIANIAAANIAMSNICHDNIDCRNIDANINDSNCCIHNCI | 08/23/22 | 06/17/25 |
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 07/26/22 | 09/07/25 |
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 07/26/22 | 09/07/25 |
NCI Outstanding Investigator Award (R35 Clinical Trial Optional) Agency: NIH Institutions: NCI | 07/26/22 | 11/07/24 |
Agency: NIH Institutions: NIDANIAAANIMHNCCIHNCI | 07/14/22 | 11/12/25 |
Agency: NIH Institutions: NIDANIAAANIMHNCCIHNCI | 07/14/22 | 11/12/25 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 07/14/22 | 07/01/25 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Agency: NIH Institutions: NCI | 06/23/22 | 09/07/25 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Agency: NIH Institutions: NCI | 06/23/22 | 09/07/25 |
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 06/14/22 | 09/07/25 |
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 06/14/22 | 09/07/25 |
Agency: NIH Institutions: NCI | 06/13/22 | 09/07/25 |
Agency: NIH Institutions: NCI | 06/13/22 | 09/07/25 |
Agency: NIH Institutions: NIAID | 05/19/22 | 12/07/24 |
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH | 05/10/22 | 05/07/25 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH | 05/10/22 | 05/07/25 |
Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH | 05/09/22 | 05/07/25 |
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH | 05/09/22 | 09/07/25 |
Agency: NIH Institutions: FICNIDCRNIDANIMHNCIORWH | 04/21/22 | 08/22/24 |
Agency: NIH Institutions: NCI | 04/13/22 | 02/28/25 |
Agency: NIH Institutions: NCI | 04/12/22 | 09/07/25 |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI | 04/11/22 | 06/17/24 |
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 04/08/22 | 11/01/24 |
Agency: NIH Institutions: ODNEINHLBINHGRINIANIAIDNIAMSNICHDNIDCDNINDSNCI | 04/08/22 | 07/01/24 |
Agency: NIH Institutions: NCI | 04/07/22 | 02/28/25 |
Agency: NIH Institutions: ODNEINHLBINHGRINIANIAIDNIAMSNICHDNIDCDNIDCRNIMHNINDSNCIORIP | 04/05/22 | 07/01/24 |
Agency: NIH Institutions: ODNEINHLBINIANIAMSNICHDNIDCDNINDSNCI | 04/05/22 | 07/01/24 |
Agency: NIH Institutions: ODNEINHLBINIANIAMSNICHDNIDCDNINDSNCI | 04/05/22 | 07/01/24 |
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIGMSNIANCI | 03/21/22 | 05/07/25 |
Agency: NIH Institutions: NIGMSNIANCI | 03/21/22 | 05/07/25 |
Agency: NIH Institutions: NCI | 03/18/22 | 05/07/25 |
Agency: NIH Institutions: NCI | 03/18/22 | 05/07/25 |
Agency: NIH Institutions: NHLBINIANIAIDNCI | 03/14/22 | 01/10/25 |
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) Agency: NIH Institutions: NIBIBNEINIANCI | 03/08/22 | 01/07/25 |
Agency: NIH Institutions: NCI | 02/25/22 | 01/23/25 |
Coupling, Energetics, and Dynamics of Atmospheric Regions Agency: NSF | 02/20/22 | 05/03/24 |
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIDCR | 02/18/22 | 05/07/25 |
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIDCR | 02/18/22 | 05/07/25 |
Agency: NIH Institutions: NCI | 01/21/22 | 05/07/25 |
Agency: NIH Institutions: NCI | 01/21/22 | 05/07/25 |
Agency: NIH Institutions: NCI | 01/21/22 | 05/07/25 |
Stimulating Access to Research in Residency (StARR) (R38) Agency: NIH Institutions: NHLBINCINIAIDNIA | 01/19/22 | 05/16/24 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 01/11/22 | 01/07/25 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMSNIDCR | 01/11/22 | 01/07/25 |
Agency: NIH Institutions: NICHDNEINHLBINHGRINIANIAAANIDCDNIDANIMHNINDSNINRNIMHDNCI | 01/10/22 | 01/07/25 |
Agency: NIH Institutions: NIMHDNEINIANIAMSNIDCDNIDANINRNCIORWH | 01/10/22 | 09/07/24 |
Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNIDDKNCCIHNCATSNCI | 01/07/22 | 12/06/24 |
Agency: NIH Institutions: NIMHDNINRNCIODPOBSSRSGMROORWH | 12/13/21 | 05/07/25 |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 11/23/21 | 11/17/24 |
Agency: NIH Institutions: NIMHDNIDCRNIEHSNIMHNCIODPOBSSRSGMRO | 11/20/21 | 05/07/24 |
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNEINHLBINHGRINIAAANIAIDNIAMSNIDCDNIDCRNIMHNINDSNCCIHNCIORWH | 11/19/21 | 04/18/24 |
Agency: NIH Institutions: NCI | 11/03/21 | 01/07/25 |
Agency: NIH Institutions: NCI | 11/03/21 | 01/07/25 |
Agency: NIH Institutions: NCI | 10/21/21 | 09/13/24 |
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI | 10/12/21 | 01/07/25 |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 10/12/21 | 10/08/24 |
Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR | 10/05/21 | 06/21/24 |
Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCIOBSSR | 10/05/21 | 06/21/24 |
Agency: NIH Institutions: OPPNETNIANIAAANIDANINRNCCIHNCI | 10/05/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 09/22/21 | 11/05/24 |
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 09/16/21 | 06/11/24 |
Agency: NIH Institutions: NCI | 09/16/21 | 06/11/24 |
Agency: NIH Institutions: NCINICHDNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCATSNLMORIPNCIPCNCEHNIOSH | 09/10/21 | 09/09/24 |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI | 09/10/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 09/10/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 09/10/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 09/10/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 09/08/21 | 10/11/24 |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 09/03/21 | 09/07/24 |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 09/03/21 | 09/07/24 |
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 09/02/21 | 09/07/24 |
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 09/02/21 | 09/07/24 |
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 09/02/21 | 09/07/24 |
Agency: NIH Institutions: NCI | 08/31/21 | 11/12/24 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) Agency: NIH Institutions: NCI | 08/31/21 | 11/12/24 |
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNICHDNCIODP | 08/11/21 | 09/10/24 |
Agency: NIH Institutions: NCI | 07/22/21 | 09/07/24 |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 07/22/21 | 09/07/24 |
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSNIBIBORIPODPOBSSRODSORWHOD | 06/30/21 | 06/30/24 |
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) Agency: NIH Institutions: NIMHDNIANIDANIEHSNIMHNCINICHDSGMROORWH | 06/25/21 | 09/07/24 |
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) Agency: NIH Institutions: NCI | 06/03/21 | 12/01/24 |
Agency: NIH Institutions: NIGMSNEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNLMNCCIHNCI | 05/19/21 | 05/07/24 |
Agency: NIH Institutions: NIDANEINHGRINIANIAAANICHDNIDCDNIMHNINDSNINRNCI | 05/19/21 | 05/07/24 |
Agency: NIH Institutions: NCI | 03/25/21 | 05/07/24 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) Agency: NIH Institutions: NCI | 03/15/21 | 03/14/24 |
Agency: NIH Institutions: NCI | 03/15/21 | 03/14/24 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 03/15/21 | 03/14/24 |
University Nuclear Leadership Program– Scholarship and Fellowship Support Agency: ID | 10/15/20 | 10/14/30 |
Agency: NIH | 05/12/20 | 05/07/24 |
Agency: NIH Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD | 05/12/20 | 05/07/24 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNLMNCCIHICs | 05/07/20 | 05/07/24 |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD | 05/05/20 | 05/07/24 |
Agency: NIH Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH | 05/05/20 | 05/07/24 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs | 05/05/20 | 05/07/24 |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD | 05/05/20 | 05/07/24 |
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI | 11/04/19 | 10/12/21 |
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA | 03/20/15 | 09/30/24 |